ArticleBlood cancer journal2015

Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis.

D Esteban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.